Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Payton

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Allergy|May 29, 2014
Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459R Pettipher, M G Hunter, C M Perkins, et al.
Haematologica|July 18, 2020
Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated miceEmily R Finch, Monique A Payton, David A Jenkins, et al.
Pediatric Blood & Cancer|December 6, 2021
Dasatinib does not exacerbate dexamethasone-induced osteonecrosis in murine models of acute lymphoblastic leukemia therapyEmily R Finch, Laura J Janke, Lie Li, et al.
Journal of Molecular Biology|April 1, 1994
Crystallization and preliminary X-ray analysis of Candida albicans phosphomannose isomeraseS Tolley, G Davies, R E Hubbard, et al.
American Journal of Medical Genetics|January 23, 2002
No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorderL Kent, E Green, J Holmes, et al.
Human Immunology|June 1, 1997
HLA-DQ alleles associate with cutaneous features of onchocerciasis. The Kaduna-London-Manchester Collaboration for Research on OnchocerciasisM E Murdoch, A Payton, A Abiose, et al.
Nature Structural Biology|May 1, 1996
The x-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 angstrom resolutionA Cleasby, A Wonacott, T Skarzynski, et al.
Pediatric Blood & Cancer|June 14, 2021
Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical modelsLaura J Janke, Jieun Kim, Monique A Payton, et al.
Plos One|May 7, 2019
Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical modelsSeth E Karol, Laura J Janke, John C Panetta, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 23, 2011
Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophilsRoy Pettipher, Shân L Vinall, Luzheng Xue, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Allergy|May 29, 2014
Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459R Pettipher, M G Hunter, C M Perkins, et al.
Haematologica|July 18, 2020
Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated miceEmily R Finch, Monique A Payton, David A Jenkins, et al.
Pediatric Blood & Cancer|December 6, 2021
Dasatinib does not exacerbate dexamethasone-induced osteonecrosis in murine models of acute lymphoblastic leukemia therapyEmily R Finch, Laura J Janke, Lie Li, et al.
Journal of Molecular Biology|April 1, 1994
Crystallization and preliminary X-ray analysis of Candida albicans phosphomannose isomeraseS Tolley, G Davies, R E Hubbard, et al.
American Journal of Medical Genetics|January 23, 2002
No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorderL Kent, E Green, J Holmes, et al.
Human Immunology|June 1, 1997
HLA-DQ alleles associate with cutaneous features of onchocerciasis. The Kaduna-London-Manchester Collaboration for Research on OnchocerciasisM E Murdoch, A Payton, A Abiose, et al.
Nature Structural Biology|May 1, 1996
The x-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 angstrom resolutionA Cleasby, A Wonacott, T Skarzynski, et al.
Pediatric Blood & Cancer|June 14, 2021
Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical modelsLaura J Janke, Jieun Kim, Monique A Payton, et al.
Plos One|May 7, 2019
Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical modelsSeth E Karol, Laura J Janke, John C Panetta, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 23, 2011
Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophilsRoy Pettipher, Shân L Vinall, Luzheng Xue, et al.
Pageof 10